Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis

BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for…
byVandana Singh
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for amyotrophic lateral sclerosis (ALS).
  • A correction was made to the Muscle and Nerve publication from December 2021 describing the results of NurOwn’s Phase 3 trial in ALS following new clinical analyses, which strengthens the company’s original conclusions from the trial.  
  • The correction results in a statistically significant treatment difference of more than 2 points for an average change from baseline in ALSFRS-R (ALS functional scale) in the pre-specified efficacy subgroup of participants with a baseline score of at least 35.
  • Related: BrainStorm Cell ALS Candidate Shows Benefit In Patients With Less Severe Disease.
  • Results of the biomarker analyses showed significant changes across multiple cerebrospinal fluid (CSF) biomarkers following NurOwn treatment, with the most potent effects observed on biomarkers related to neuroprotection and neuroinflammation.
  • The company ended Q2 with cash, cash equivalents, and short-term bank deposits of approximately $12.2 million.
  • Price Action: BCLI shares are up 12.95% at $3.95 during the market session on the last check Monday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

These 2 High Yielders Could Benefit From The Supply Crunch Caused By The Russia-Ukraine War

By Robert Kuczmarski
September 29, 6:16 PM
Since the Energy Select Sector SPDR FUN (ARCA: XLE) is down roughly 16% over the past month, it may be a good time to shop around for oversold equities in the oil and gas sector. Although investors are concerned about a recession slowing down the economy, natural gas prices are still at record highs.

DCP